Previous Article | Next Article ![]()
Applied and Environmental Microbiology, April 2002, p. 2026-2030, Vol. 68, No. 4
0099-2240/02/$04.00+0 DOI: 10.1128/AEM.68.4.2026-2030.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Department of Chemical and Environmental Engineering,1 Environmental Toxicology Program, University of California, Riverside, California 925212
Received 19 October 2001/ Accepted 25 January 2002
|
|
|---|
|
|
|---|
Although OPH hydrolyzes a wide range of organophosphates, the effectiveness of hydrolysis varies dramatically. For example, some widely used organophosphorus insecticides such as methyl parathion, chlorpyrifos, and diazinon are hydrolyzed 30 to 1,000 times slower than is the preferred substrate, paraoxon (5). This reduction in catalytic rate is due to the unfavorable interaction of these substrates with the active sites involved in catalysis and/or structural functions (10). Site-directed mutagenesis has been applied to the various residues involved in the active sites, resulting in OPH mutants with improved catalytic characteristics against paraoxon, sarin, and soman (4, 10, 11, 22). Since the kinetic characteristics of OPH can be altered with relatively few amino acid substitutions, it may be possible to create variants with improved activity against other poorly degraded insecticides or chemical warfare agents. Although the three-dimensional structure of OPH has been elucidated previously (1), identifying all the amino acids responsible for substrate specificity and those that might give rise to extended specificity remains an overwhelming challenge. To this end, in vitro directed evolution is perhaps the most useful way to sample this sequence flexibility in a simple and rapid fashion (16, 20).
Although improved variants can be evolved by screening a library of cells with OPH expressed intracellularly, this method is inadequate for organophospates, which are not readily taken up by cells (17). In order to provide free access to substrates and to screen for variants with truly improved kinetic properties, we have developed a generalized selection scheme using a surface-display OPH library for the isolation of improved variants. Enzymes with up to 25-fold-higher activity were generated after only two rounds of screening. With this approach, it is possible that novel OPH variants with improved activity against other organophosphorus pesticides such as malathion, chlorpyrifos, and diazinon and chemical warfare agents such as sarin and soman can be similarly created.
|
|
|---|
M15 Tn10 (Tetr)]) was used in all experiments. Plasmid pOPK132 harboring the lpp-ompA-opd fusion was used as the source of the opd gene (17). A low-copy-number plasmid, pK184 (9), was used for intermediate cloning. Plasmid pINCOP containing the truncated ice nucleation protein (INPNC) anchor was used to display OPH on the cell surface of E. coli (19).
DNA shuffling.
The 1.1-kb opd gene from pOPK132 was amplified using primers 5'-AATTTCGGATCCCGGGATGC-3' and 5'-GGGGAATTCAAGCTTCCAAAAAAAAGCCCGCTCATTAGGCGGGCTGCGTCATACGCCCAAGGTCGGTGACAG-3'. The amplified fragments were digested with restriction enzymes BamHI and HindIII and inserted into the vector pK184 to generate pKOP, which was used as a template for DNA shuffling. The procedures for DNA shuffling were performed as described previously (20). The opd fragments for the shuffling reactions were obtained by PCR using two primers, DB1 (5'-TGCGGGCCTCTTCGCTATTA-3') and UH1 (5'-CCCCAGGCTTTACACTTTAT-3'), which flank the opd gene by approximately 100 bp. Following purification with the Wizard PCR purification kit (Promega, Madison, Wis.), the 1.3-kb fragments were digested with 0.01 U of DNase I (Boehringer Mannheim) at 15°C for 8 min. The reaction was stopped by heating the reaction mixture at 90°C for 10 min. DNA fragments of less than 50 bp were isolated from a 2% agarose gel with the DEAE cellulose membrane and subsequently purified by extraction with phenol and chloroform. Approximately 2 µg of DNA was mixed and reassembled in 100 µl of a primerless PCR mixture with the EasyStart (Molecular Bio-Products) mix and Taq DNA polymerase (Promega). Conditions for PCR were as follows: 5 min at 94°C and 50 cycles of 1 min at 94°C, 1 min at 45°C, and 1.5 min at 72°C, followed by 10 min at 72°C (12). After a 1:40 dilution of the primerless PCR products, DNA amplification was carried out in the presence of the M13/pUC sequencing primer and the M13/pUC reverse sequencing primer. A PCR program of 5 min at 95°C and 35 cycles of 1 min at 95°C, 1 min at 53°C, and 1.5 min at 72°C, followed by 10 min at 72°C, was used. The 1.1-kb amplification product was recovered using the Gene Clean II kit (QBIOGENE), digested with BamHI and HindIII, and subcloned into similarly digested pINCOP to generate a library of OPH variants fused to the INPNC anchor. The resulting plasmids were used to transform E. coli XL1-Blue by the CaCl2 method.
Screening of OPH variants.
A solid-phase top agar plate assay based on the formation of a yellow product (p-nitrophenol) from methyl parathion was developed for the selection of OPH with an improved hydrolysis rate. Single colonies of transformed E. coli were streaked onto M9 plates supplemented with 0.1% tryptone, 0.05% yeast extract, 0.1% Casamino Acids, 0.2% glucose, 100 µM ampicillin, and 10 µM CoCl2 to promote growth and OPH activity without increasing the background color. After a 48-h incubation at 30°C, a thin layer of 0.7% agarose containing 50 mM phosphate-citrate buffer (pH 8.0) and 0.5 mM methyl parathion was laid over the mixture. After 1 h of incubation at 37°C, colonies were selected based on the intensity of the yellow color from the hydrolyzed product p-nitrophenol. Any clones that appeared to have a larger yellow halo than that of the wild-type OPH were selected for rescreening. For each potential clone, cells were removed directly from the agar plate, resuspended in 200 µl of 50 mM phosphate-citrate buffer (pH 8.0) containing 0.5 mM methyl parathion and 10% methanol, and rescreened using a 96-well microplate reader (Bio-Rad 3550-UV) at 37°C. Hydrolysis of methyl parathion was measured at 405 nm for 30 min. The initial rate was divided by the turbidity measured at 595 nm of each well to provide a measure of specific activity. Clones with activity at least two times higher than that of the wild type were selected. The selected clones were cultured in Luria-Bertani medium for 45 h at 30°C, and the activity was measured using a Beckman model DU-640 spectrophotometer at 37°C. Cultured variants were resuspended in 50 mM phosphate-citrate buffer (pH 8.0) containing 0.5 mM methyl parathion and 10% methanol to an optical density at 600 nm (OD600) of 0.2. Whole-cell activity was expressed as the initial change in absorbance at 410 nm due to p-nitrophenol formation.
DNA sequencing.
Variants were sequenced in both forward and reverse directions with the automated dye terminator kit and an Applied Biosystems 282A sequencer. Small-scale isolation of plasmid DNA for sequencing was carried out with the Wizard Plus Minipreps DNA purification system (Promega).
Immunoblotting.
One milliliter of cells (OD600 = 1) was sonicated for 2 min. After the debris was removed by centrifugation, 100 µl of the supernatant was combined with 20 µl of disruption buffer (62.5 mM Tris-HCl [pH 6.8], 10% glycerol, 2% [wt/vol] sodium dodecyl sulfate [SDS], 5% 2-mercaptoethanol, 0.05% [wt/vol] bromophenol blue) and boiled for 10 min. Twenty microliters of samples was then electrophoresed through SDS-12.5% (wt/vol) polyacrylamide gels prior to immunoblotting analysis. Immunoblotting was performed using a Bio-Rad Immun-Blot GAR-AP kit (Bio-Rad, Hercules, Calif.). Antisera against INPNC were used as the first antibody (19). Prestained low-range protein markers (Bio-Rad) were utilized for estimation of protein molecular weights.
Purification of intracellularly expressed variants.
To determine the specific activities of the OPH variants, the opd genes were excised with BamHI and HindIII and ligated into pPROEXHTa (GIBCO BRL) to generate pHOP. This plasmid allowed the intracellular expression of the OPH variant as an N-terminal fusion to a hexahistidine tag (His6). For the purification of the variants, plasmid-bearing bacterial cultures were grown in 200 ml of Terrific broth supplemented with ampicillin to a final concentration of 100 µg/ml at 30°C and induced with 1.0 mM isopropyl-ß-D-thiogalactopyranoside (IPTG) at an OD600 of 1.0. Cell pellets were resuspended in 30 ml of binding buffer (50 mM sodium phosphate [pH 8.0], 300 mM NaCl, and 1% Triton X-100) with 0.1 mM CoCl2 added. Benzonase (Novagen) and the protease inhibitor 4-(2-aminoethyl)benzenesulfonyl fluoride (Calbiochem) were added at 37°C for 20 min. Cells were cooled to 0°C and passed through a French pressure cell (15,000 to 20,000 lb/in2). The solution was centrifuged for 10 min at 20,000 x g. The resulting solution was added to a His·Bind Quick column (Novagen), which was prewashed with the binding buffer. The column was washed with 25 ml of binding buffer, followed by 25 ml of washing buffer (50 mM phosphate [pH 8.0], 500 mM NaCl, 10% glycerol, and 25 mM imidazole). Enzymes were eluted with 5 ml of elution buffer (50 mM sodium phosphate [pH 8.0], 300 mM NaCl, 5% glycerol) containing 200 mM imidazole. All eluted fractions were tested for OPH activity and protein purity by SDS-polyacrylamide gel electrophoresis. Fractions with the highest OPH activity were pooled, dialyzed in 50 mM phosphate-citrate buffer (pH 8.0) supplemented with 0.1 mM CoCl2, and used for specific activity analyses.
OPH assay.
Purified variants were resuspended in 1 ml of 50 mM phosphate-citrate buffer (pH 8.0) containing 0.5 mM methyl parathion and 10% methanol in 1.5-ml disposable methacrylate cuvettes (Fisher). The change in absorbance (410 nm, e410 = 16,500 M-1 cm-1 for p-nitrophenol) was measured with a Beckman DU-60 spectrophotometer for 5 min at 37°C. All assays were preformed in triplicate. Enzyme concentrations were determined according to the Bradford method (Bio-Rad) using bovine serum albumin as the standard. Specific activities were expressed as units (micromoles of p-nitrophenol produced per minute) per milligram of protein.
|
|
|---|
Directed evolution requires the screening of a large number of variants, since most mutations or recombinations are either neutral or deleterious. In this regard, colorimetric (visual) assays are convenient for rapid and sensitive screening. A solid-phase top agar plate assay based on the formation of a yellow product (p-nitrophenol) from methyl parathion (Fig. 1A) was developed for the selection of OPH with an improved hydrolysis rate. Transformants were grown on M9 plates, and a thin layer of agarose containing 0.5 mM methyl parathion was then laid on top of the plate. The intensity of the yellow color formed after 1 h was used as a preliminary screen for improved activity (Fig. 1B). All potential clones identified were rescreened in a 96-well microplate assay using citrate-phosphate buffer (pH 8) containing 0.5 mM methyl parathion. Because the methyl parathion concentrations (0.5 mM) used in the screening assay are comparable to the reported Km value of 0.8 mM, the assay should favor the selection of variants with improved kcat rather than improved kcat/Km.
![]() View larger version (24K): [in a new window] |
FIG. 1. Principles of top agar prescreening assays for E. coli colonies displaying OPH variants. (A) Hydrolysis of methyl parathion by OPH into p-nitrophenol (a yellow product) and dimethylthiophosphoric acid. (B) Selection of potential variants by comparing the rates of p-nitrophenol (yellow) formation within 1 h. Colonies with high intensities of yellow color are indicated by arrows.
|
![]() View larger version (31K): [in a new window] |
FIG. 2. Comparisons of OPH activities and expression of improved variants and the wild-type (WT) OPH. (A) Relative whole-cell activities of the surface-displayed variants. (B) Western blot of INPNC-OPH fusion of each variant. (C) Specific activities of selected purified variants. Rates are normalized to that of the wild-type OPH.
|
The expression levels of different variants were probed by Western blot analysis with the INPNC antisera (Fig. 2B). All positive variants showed essentially the same level of expression relative to that of the wild-type OPH, indicating that changes in the activities of the variants were not the result of changes in protein expression.
Selected variants from the first and second rounds (2H2, 5A6, 6D4, 21G12, 22D8, and 22A11) were excised from INPNC and expressed as a His-tagged fusion in the cytoplasm. Individual variants were purified using a Ni-resin column, and the catalytic properties against methyl parathion were determined. Similar to results with whole-cell assays, the specific activities of the purified OPH variants were all higher than that of the wild-type OPH (Fig. 2C). Although the extent of improvement was different, the trend was well correlated with the whole-cell screening assay. The best variant, 22A11, was 25-fold more active than the wild type. Thus, surface display of enzymes presents a new strategy for the isolation of improved variants based on catalytic turnover without any limitation on substrate accessibility.
Sequence and structural analysis of evolved OPHs.
The molecular structure of OPH has been determined in the presence of a nonhydrolyzable inhibitor, diethyl 4-methylbenzyl phosphonate (21), and Fig. 3 shows the side views of the wild-type OPH with this inhibitor (green). Residues in the small (red; Gly60, Ile106, Leu303, and Ser308), large (purple; His254, His257, Leu271, and Met317), and leaving group (yellow; Trp131, Phe132, Phe306, and Tyr309) binding pockets are highlighted (21). For most substrates with a nitrophenolate as the leaving group, the small and large binding pockets could accommodate a variety of substituents attached to the phosphorus center, including methyl, ethyl, isopropyl, and phenyl groups (7, 8). However, previous studies with the substrate specificity of OPH revealed that the activities for dimethyl-substituted substrates are significantly lower than those for diethyl-substituted substrates (2, 8). This observation suggests that the two ethoxy groups contribute greatly to the binding interactions with the substrates. Because methyl parathion is a smaller substrate containing two methoxy groups, mutations toward higher activity for methyl parathion are likely to favor the formation of a smaller binding pocket.
![]() View larger version (101K): [in a new window] |
FIG. 3. Structure of OPH in the presence of a nonhydrolyzable inhibitor, diethyl 4-methylbenzyl phosphonate (green). The residues for the large (purple), small (red), and leaving group (yellow) binding pockets are highlighted. Substitutions found in first- and second-round variants are indicated (brown).
|
|
View this table: [in a new window] |
TABLE 1. Amino acid substitutions and silent mutations of the variants
|
With the success that we achieved with directed evolution of OPH for improved hydrolysis of methyl parathion, we believe that we can easily extend this method in creating OPH variants with improved activity against other commonly used but poorly degraded insecticides such as diazinon and chlorpyrifos and against chemical warfare agents such as sarin and soman.
We thank Mark Shimazu for constructing the plasmid pINCOP.
* Corresponding author. Mailing address for Wilfred Chen: Department of Chemical and Environmental Engineering, University of California, Riverside, CA 92521. Phone: (909) 787-2473. Fax: (909) 787-5696. E-mail: Wilfred{at}engr.ucr.edu. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»